Direktorat Registrasi ObatValid

OXALIPLATIN HOSPIRA

by '-'

BPOM Number: DKI1848100143A1
Approved: 10 January 2025
Expiry: 28 August 2023
Form: INJEKSI

About This Registration

OXALIPLATIN HOSPIRA is a BPOM-registered direktorat registrasi obat in Indonesia, registered under number DKI1848100143A1. Its current registration status is Valid, with the licence valid until 28 August 2023. The product is registered to TEMPO SCAN PACIFIC TBK - INDONESIA. BPOM first approved this registration in September 2020. All registration data is sourced directly from the official BPOM public database and updated daily.

Registration Details

Application: newaero
Packaging: DUS, 1 VIAL @ 20 ML
Department: Direktorat Registrasi Obat

Retail Audit Service

Get detailed market intelligence for this product across Indonesian retail channels

Multiple cities available

Custom questionnaires

Professional shoppers

Detailed reporting

Starting from $50 per city

What's included in the audit service?

Stock availability and positioning verification

Price checking and competitor analysis

Display quality and promotional material assessment

Store condition and customer experience evaluation

Custom questions tailored to your research needs

Professional photographs and detailed reports

Registered Owners

TEMPO SCAN PACIFIC TBK - INDONESIA
KAB. BEKASI
NPWP: 010007813092000
owner
View profile →

Manufacturing Sites

TEMPO SCAN PACIFIC TBK - INDONESIA
KAB. BEKASI
primary
View profile →

Market Intelligence

Owner Portfolio: TEMPO SCAN PACIFIC TBK - INDONESIA holds 190 BPOM registrations
Manufacturer Scale: TEMPO SCAN PACIFIC TBK - INDONESIA produces 190 registered products
Registration Age: Registered for 5 years, 11 months
Expiry Status: Expired 1101 days ago

FDA Cross-Reference

via openFDA

Generic Name: OXALIPLATIN
Product Type: HUMAN PRESCRIPTION DRUG
Route of Administration: INTRAVENOUS

Data sourced from the U.S. FDA drug label database (openFDA). May not exactly match this product variant.

Is this your product?